Martingale Asset Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $569K | Sell |
62,343
-10,914
| -15% | -$99.5K | 0.01% | 593 |
|
|
2025
Q1 | $582K | Sell |
73,257
-6,926
| -9% | -$55.1K | 0.01% | 573 |
|
|
2024
Q4 | $435K | Buy |
80,183
+33,106
| +70% | +$180K | 0.01% | 630 |
|
|
2024
Q3 | $340K | Buy |
47,077
+16,717
| +55% | +$121K | 0.01% | 693 |
|
|
2024
Q2 | $330K | Buy |
30,360
+11,216
| +59% | +$122K | 0.01% | 680 |
|
|
2024
Q1 | $359K | Buy |
19,144
+1,000
| +6% | +$18.7K | 0.01% | 679 |
|
|
2023
Q4 | $393K | Buy |
+18,144
| New | +$393K | 0.01% | 654 |
|
|
2023
Q3 | – | Sell |
-16,914
| Closed | -$795K | – | 840 |
|
|
2023
Q2 | $795K | Hold |
16,914
| – | – | 0.02% | 507 |
|
|
2023
Q1 | $710K | Buy |
+16,914
| New | +$710K | 0.01% | 532 |
|